14-100538096-G-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001385089.1(BEGAIN):​c.1712C>G​(p.Ala571Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000987 in 1,580,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00010 ( 0 hom. )

Consequence

BEGAIN
NM_001385089.1 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.34
Variant links:
Genes affected
BEGAIN (HGNC:24163): (brain enriched guanylate kinase associated) Predicted to be involved in regulation of postsynaptic neurotransmitter receptor activity. Predicted to act upstream of or within evoked excitatory postsynaptic potential. Predicted to be located in dendrite; nucleus; and presynapse. Predicted to be active in glutamatergic synapse and postsynapse. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.1143924).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BEGAINNM_001385089.1 linkc.1712C>G p.Ala571Gly missense_variant Exon 7 of 7 ENST00000554140.3 NP_001372018.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BEGAINENST00000554140.3 linkc.1712C>G p.Ala571Gly missense_variant Exon 7 of 7 5 NM_001385089.1 ENSP00000451125.2 G3V3A2

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
11
AN:
152092
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000121
AC:
25
AN:
206236
AF XY:
0.0000971
show subpopulations
Gnomad AFR exome
AF:
0.0000744
Gnomad AMR exome
AF:
0.000134
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000219
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000101
AC:
145
AN:
1428834
Hom.:
0
Cov.:
31
AF XY:
0.000102
AC XY:
72
AN XY:
708236
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32390
American (AMR)
AF:
0.0000984
AC:
4
AN:
40630
Ashkenazi Jewish (ASJ)
AF:
0.0000415
AC:
1
AN:
24092
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39164
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81682
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49878
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4758
European-Non Finnish (NFE)
AF:
0.000122
AC:
134
AN:
1097522
Other (OTH)
AF:
0.000102
AC:
6
AN:
58718
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000723
AC:
11
AN:
152092
Hom.:
0
Cov.:
33
AF XY:
0.0000808
AC XY:
6
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41424
American (AMR)
AF:
0.0000654
AC:
1
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
67976
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000133
Hom.:
0
Bravo
AF:
0.0000756
ExAC
AF:
0.000108
AC:
13

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 07, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1655C>G (p.A552G) alteration is located in exon 6 (coding exon 6) of the BEGAIN gene. This alteration results from a C to G substitution at nucleotide position 1655, causing the alanine (A) at amino acid position 552 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.015
.;T;.;T
Eigen
Benign
-0.21
Eigen_PC
Benign
-0.12
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.70
T;.;T;T
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.11
T;T;T;T
MetaSVM
Benign
-0.82
T
MutationAssessor
Benign
1.4
.;L;.;L
PhyloP100
3.3
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
-0.90
.;N;.;N
REVEL
Benign
0.070
Sift
Benign
0.088
.;T;.;T
Sift4G
Benign
0.21
.;T;.;T
Polyphen
0.021
.;B;.;B
Vest4
0.082, 0.087
MVP
0.22
MPC
0.49
ClinPred
0.026
T
GERP RS
3.7
Varity_R
0.12
gMVP
0.25
Mutation Taster
=74/26
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs781500772; hg19: chr14-101004433; API